Mapping cancer heterogeneity: a consensus network approach to subtypes and pathways
Briefings in Bioinformatics · 31.08.2025 · 26 (5)
DOI: 10.1093/bib/bbaf452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 04.09.2025. Verfasst von Geng-Ming Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, National Taiwan Normal University, 88 Sec.4 Ting-Chou Rd., Taipei 116, Taiwan. Hauptthemen laut MEDLINE: Neoplasms, Genetic Heterogeneity, Gene Regulatory Networks. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science and Technology Council of Taiwan.
Abstract (Originalsprache)
We introduce consensus MSClustering, an unsupervised hierarchical network approach that integrates multi-omics data to identify molecular subtypes and conserved pathways across diverse cancers. Using a novel heterogeneity index, we selected 167 key genes with functionally coherent roles validated through Gene Ontology analysis. Applied to 2439 tumors spanning 10 cancer types—and successfully extended to 2675 tumors (12 types) including cases with incomplete molecular data—MSClustering demonstrated: (i) precise classification of major cancer types and breast cancer molecular subtypes; (ii) discovery of novel pan-cancer squamous metaplastic signatures; (iii) exceptional prognostic stratification (log-rank P = 2.3 × 10−46); and (iv) superior performance over existing methods (COCA/SNF) in classification accuracy, cluster robustness, and computational efficiency. The method’s multi-scale architecture uniquely resolves breast cancer heterogeneity across biological resolution levels. Pathway analysis further revealed four key oncogenic programs—proteoglycan signaling, chromosomal stability, VEGF-mediated angiogenesis, and drug metabolism—along with disruptions in immune and digestive system functions. This integrative framework marks a significant advancement in cancer genomics by enabling more refined molecular classification, enhanced prognostic insights, and deeper understanding of disease mechanisms. These results highlight the potential of MSClustering to inform the development of clinically relevant biomarkers and support more personalized strategies in precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physics, National Taiwan Normal University, 88 Sec.4 Ting-Chou Rd., Taipei 116, Taiwan.
ORCID-Profile: Chi-Ming Chen
Förderung
- National Science and Technology Council of Taiwan
Zitieren
APA
Hu, G. M., Chen, H. W., & Chen, C. M. (2025). Mapping cancer heterogeneity: a consensus network approach to subtypes and pathways. Briefings in Bioinformatics, 26(5). https://doi.org/10.1093/bib/bbaf452
Vancouver
Hu GM, Chen HW, Chen CM. Mapping cancer heterogeneity: a consensus network approach to subtypes and pathways. Briefings in Bioinformatics. 2025;26(5). doi:10.1093/bib/bbaf452
BibTeX
@article{Hu2025,
author = {Hu, Geng-Ming and Chen, Hsin-Wei and Chen, Chi-Ming},
title = {Mapping cancer heterogeneity: a consensus network approach to subtypes and pathways},
journal = {Briefings in Bioinformatics},
year = {2025},
volume = {26},
number = {5},
doi = {10.1093/bib/bbaf452}
}
EUVIMED